Intellia Therapeutics Appoints Derek Hicks as Chief Business Officer

3 years ago

CAMBRIDGE, Mass., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ: NTLA), a leading genome editing company focused on…

Tilray to Announce Second Quarter Fiscal 2022 Financial Results on January 10, 2022

3 years ago

Company to Also Host Fireside Chat at the 24th Annual ICR Conference on January 10, 2022NEW YORK and LEAMINGTON, Ontario,…

Eton Pharmaceuticals and ANI Pharmaceuticals Announce Commercial Availability of Carglumic Acid Tablets, the First and Only FDA-Approved Generic Version of Carbaglu® (carglumic acid)

3 years ago

Product is now available exclusively through Anovo specialty pharmacyProduct is stable at room temperature while Carbaglu® requires refrigerationEton Cares patient…

InMed Pharmaceuticals Announces Publication of Peer-Reviewed Article on the Use of CBN as a Potential Treatment for Glaucoma

3 years ago

VANCOUVER, British Columbia, Dec. 20, 2021 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader…

GBS Inc. to Participate in the Upcoming January Virtual Investor Conferences

3 years ago

NEW YORK, Dec. 20, 2021 (GLOBE NEWSWIRE) -- GBS (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing…

COVID-19 Costs Employers Nearly $1 Billion per Week due to Lost Time from Work According to Integrated Benefits Institute Analysis

3 years ago

Employees who get COVID-19 will lose an estimated $33.3 billion in wagesSan Francisco, Dec. 20, 2021 (GLOBE NEWSWIRE) -- SAN…

Senti Bio and Dynamics Special Purpose Corp. Announce Business Combination Agreement to Create Publicly Listed Company Pioneering Gene Circuit-Engineered Cell and Gene Therapies

3 years ago

- Business combination with Dynamics Special Purpose Corp. (Nasdaq: DYNS) is expected to provide more than $296 million in gross…

Diffusion Pharmaceuticals to Present at H.C. Wainwright BioConnect, Participate in Biotech Showcase and Bio Partnering at JPM during “J.P. Morgan Week 2022”

3 years ago

CHARLOTTESVILLE, Va., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), a biopharmaceutical company…

Editas Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for EDIT-301 for the Treatment of Transfusion-Dependent Beta Thalassemia

3 years ago

EDIT-301 is in development as a transformative, one-time treatment for people living with transfusion-dependent beta thalassemia Editas Medicine will initiate…

Finch Therapeutics Appoints Joseph Vittiglio, JD, as Chief Business and Legal Officer

3 years ago

SOMERVILLE, Mass., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch” or “Finch Therapeutics”) (Nasdaq: FNCH), a clinical-stage…

Show more Posts
Show previous Posts